MSF calls for insulin manufacturers to provide $1 injection pens globally, emphasizing current high prices and limited access ...
Analysts have struggled to estimate the size of the compounded market for weight-loss drugs because their sale is not tracked ...
Bullish option flow detected in Eli Lilly (LLY) with 38,006 calls trading, 1.2x expected, and implied vol increasing over 1 point to 32.28%. Nov-24 700 calls and Nov-24 815 calls are the most active ...
Earlier this month, the FDA said the Eli Lilly tirzepatide injection shortage was resolved. Also Read: Novo Nordisk, Eli Lilly Could Face Downward Pressure Despite Market Dominance From ...
A U.K. watchdog has declined to endorse Eli Lilly’s (NYSE ... have been eligible for treatment with donanemab. Donanemab, an injection for intravenous infusion every four weeks, is indicated ...
Eli Lilly said new results from a Phase 3 study of its tirzepatide showed weekly injections in adults with pre-diabetes and obesity or overweight resulted in sustained weight loss, with nearly 99% ...
Another issue for investors is that Eli Lilly adjusted its guidance for the year, now projecting its adjusted EPS to fall ...
Skyrocketing demand for weight loss and diabetes drugs has forced Eli Lilly and Novo Nordisk, to invest billions to increase ...
Eli Lilly has seen massive returns this year and is one of the most expensive healthcare stocks in the world. Its new products have strong growth prospects, but their potential may still be ...
Powered by its popular GLP-1 weight loss drugs, Eli Lilly's stock (NYSE: LLY) has had a strong run this year, up more than 55%. However, the company's success goes back much further, with the ...
Eli Lilly said on Monday it sued three medical spas and online vendors for selling products that claimed to contain tirzepatide, the main ingredient in its popular weight-loss medicine ...
Eli Lilly (NYSE: LLY) is the most valuable healthcare stock in the world, with a market capitalization north of $800 billion. In the past 12 months, its shares have risen by more than 50% ...